Figure 1.
Figure 1. Kaplan Meier Plot of Survival in Patients with ≥50% and <25% Reduction in Palpable Spleen Length During Ruxolitinib Therapy

Kaplan Meier Plot of Survival in Patients with ≥50% and <25% Reduction in Palpable Spleen Length During Ruxolitinib Therapy

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal